3004.90.92.19 - Containing hydralazine or its salts 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3004.90.92.19, specifically classifies medicaments containing hydralazine or its salts. Hydralazine is a vasodilator medication primarily used to treat high blood pressure. The classification applies to products in measured doses or for retail sale, consistent with the broader scope of heading 3004, which covers medicaments for therapeutic or prophylactic uses.
This subcategory is distinguished from its siblings by its specific active pharmaceutical ingredient. For instance, it is separate from 3004.90.92.16 (metoprolol), 3004.90.92.17 (amiodarone), and 3004.90.92.18 (diltiazem), as each of these classifications is based on a different active compound used for cardiovascular conditions. The "Other" subcategory (3004.90.92.21) exists to capture cardiovascular medicaments not otherwise specified within this particular grouping.
As this is a leaf node, there are no further subcategories. Therefore, classification decisions within 3004.90.92.19 will hinge on the confirmed presence of hydralazine or its pharmaceutically acceptable salts as the primary therapeutic agent in the medicament. This ensures accurate tariff application for products specifically formulated to treat conditions responsive to hydralazine.